Cargando…

Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma

Cadherin-23(CDH23) mediates homotypic and heterotypic cell-cell adhesions in cancer cells. However, the epigenetic regulation, the biological functions, the mechanisms and the prognostic value of CDH23 in diffuse large B-cell lymphoma (DLBCL) are still unclear. The Gene Expression Profiling Interact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Baoping, Guo, Xiaochuan, Huang, Lefu, Wang, Bin, Wang, Weixia, Han, Dong, Zhang, Weijing, Zhong, Kaili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312441/ https://www.ncbi.nlm.nih.gov/pubmed/34252883 http://dx.doi.org/10.18632/aging.203268

Ejemplares similares

CDH23 Methylation Status and Presbycusis Risk in Elderly Women
por: Bouzid, Amal, et al.
Publicado: (2018)

Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia
por: Balan, Shabeesh, et al.
Publicado: (2021)

CDH6 as a prognostic indicator and marker for chemotherapy in gliomas
por: Meng, Ming, et al.
Publicado: (2022)

A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma
por: Cen, Hong, et al.
Publicado: (2015)

CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer
por: Hibi, K, et al.
Publicado: (2004)

CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer
por: Yu, Qi-Ming, et al.
Publicado: (2012)

Methylation and Polymorphism in CDH1 Gene Promoter Among Patients with Diffuse Gastric Cancer
por: Vishteh, Mohadeseh Naghi, et al.
Publicado: (2022)

Role of CDH23 as a prognostic biomarker and its relationship with immune infiltration in acute myeloid leukemia
por: Yang, Jiao, et al.
Publicado: (2022)

Clinical Relevance of CDH1 and CDH13 DNA-Methylation in Serum of Cervical Cancer Patients
por: Abudukadeer, Abida, et al.
Publicado: (2012)

Compound Heterozygosity of the Functionally Null Cdh23(v-ngt) and Hypomorphic Cdh23(ahl) Alleles Leads to Early-onset Progressive Hearing Loss in Mice
por: Miyasaka, Yuki, et al.
Publicado: (2013)

cdh23 affects congenital hearing loss through regulating purine metabolism
por: Yang, Shu, et al.
Publicado: (2023)

Methylation pattern of CDH1 promoter and its association with CDH1 gene expression in cytological cervical specimens
por: Holubeková, Veronika, et al.
Publicado: (2016)

Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma
por: Shen, Ye, et al.
Publicado: (2022)

A CDH23 missense variant in Beauceron dogs with non‐syndromic deafness
por: Abitbol, Marie, et al.
Publicado: (2022)

SAT604 An Extensively Invasive Giant Prolactinoma Associated With CDH23 Mutation
por: Alghamdi, Balgees, et al.
Publicado: (2023)

DNA methylation-mediated silencing of miR-204 is a potential prognostic marker for papillary thyroid carcinoma
por: Xia, Fada, et al.
Publicado: (2019)

Germline CDH1 deletions in hereditary diffuse gastric cancer families
por: Oliveira, Carla, et al.
Publicado: (2009)

Methylation pattern of CDH13 gene in digestive tract cancers
por: Hibi, K, et al.
Publicado: (2004)

The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies
por: Shen, Zhisen, et al.
Publicado: (2016)

DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma
por: Xia, Wenjie, et al.
Publicado: (2015)

DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer
por: Zhang, Lei, et al.
Publicado: (2017)

Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma
por: Pu, Weilin, et al.
Publicado: (2016)

Identification of CDH23 mutations in Korean families with hearing loss by whole-exome sequencing
por: Woo, Hae-Mi, et al.
Publicado: (2014)

MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1
por: CHENG, LIN, et al.
Publicado: (2014)

Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC
por: Xue, Ruilin, et al.
Publicado: (2014)

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)

Alternative Splicing of Cdh23 Exon 68 Is Regulated by RBM24, RBM38, and PTBP1
por: Li, Nana, et al.
Publicado: (2020)

Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas
por: Tzankov, Alexandar, et al.
Publicado: (2007)

CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma
por: Sun, Jie, et al.
Publicado: (2021)

PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients
por: Draaisma, Kaspar, et al.
Publicado: (2015)

Expression and Prognostic Significance of Cadherin 4 (CDH4) in Renal Cell Carcinoma
por: Zhou, Xiaohui, et al.
Publicado: (2020)

Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer
por: Ku, Su-Chi, et al.
Publicado: (2022)

Diagnostic investigations of PLA2G16 and CDH11 expression levels as independent prognostic markers of human osteosarcoma
por: Azarsina, Salman, et al.
Publicado: (2016)

Epigenetic Silencing of TFPI-2 in Canine Diffuse Large B-Cell Lymphoma
por: Ferraresso, Serena, et al.
Publicado: (2014)

Presence of interstereocilial links in waltzer mutants suggests Cdh23 is not essential for tip Link formation
por: Rzadzinska, A.K., et al.
Publicado: (2009)

Discovery of CDH23 as a Significant Contributor to Progressive Postlingual Sensorineural Hearing Loss in Koreans
por: Kim, Bong Jik, et al.
Publicado: (2016)

Novel compound heterozygous CDH23 variants in a patient with Usher syndrome type I
por: Okano, Satomi, et al.
Publicado: (2019)

Identification of Novel CDH23 Variants Causing Moderate to Profound Progressive Nonsyndromic Hearing Loss
por: Ramzan, Khushnooda, et al.
Publicado: (2020)

RAC1, a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma
por: Wu, Xue, et al.
Publicado: (2022)

Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma
por: Li, Feng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jvcigcnd19e183s3ktslsmtbph